Emily Lutterloh
Impact in
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Antibiotic Use and Resistance 5
-
- Antifungal resistance and susceptibility 10
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 4
- Infection Control in Healthcare 3
- Antimicrobial Resistance in Staphylococcus 3
- SARS-CoV-2 detection and testing 3
- Co-authors
- K SouthwickSudha ChaturvediMonica QuinnEli S. RosenbergDina HoeferHoward A. ZuckerVajeera DorabawilaUrsula E. Bauer
- Journals
- American Journal of Infection Control (6 papers)MMWR Morbidity and Mortality Weekly Report (6 papers)Open Forum Infectious Diseases (4 papers)Infection Control and Hospital Epidemiology (3 papers)Journal of the American Podiatric Medical Association (2 papers)
- Partner nations
- United StatesCanadaMalawi
In The Last Decade
Emily Lutterloh
32 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 107
- Infectious Diseases 822
- Applied Microbiology and Biotechnology 61
- Modeling and Simulation 95
- Clinical Biochemistry 136
- Health 153
Countries citing papers authored by Emily Lutterloh
This map shows the geographic impact of Emily Lutterloh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Lutterloh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Lutterloh more than expected).
Fields of papers citing papers by Emily Lutterloh
This network shows the impact of papers produced by Emily Lutterloh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Lutterloh. The network helps show where Emily Lutterloh may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Lutterloh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 11 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 91 | |
| 7 | 2021 | 17 | |
| 8 | 2020 | 1 | |
| 9 | 2019 | 105 | |
| 10 | 2017 | 3 | |
| 11 | 2016 | 32 | |
| 12 | 2015 | 4 | |
| 13 | 2015 | 1 | |
| 14 | 2015 | 3 | |
| 15 | 2015 | 2 | |
| 16 | Notes from the field: Adverse events associated with administration of simulation intravenous fluids to patients--United States, 2014. | 2015 | 3 |
| 17 | 2014 | 4 | |
| 18 | 2013 | 13 | |
| 19 | 2012 | 3 | |
| 20 | 2007 | 135 |
About Emily Lutterloh
Emily Lutterloh is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Clinical Biochemistry, Modeling and Simulation and Epidemiology, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (10 papers), Fungal Infections and Studies (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Antibiotic Use and Resistance (5 papers), COVID-19 Clinical Research Studies (4 papers), Infection Control in Healthcare (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and SARS-CoV-2 detection and testing (3 papers). The work is most often cited by research in Infectious Diseases (822 citations), Applied Microbiology and Biotechnology (61 citations), Modeling and Simulation (95 citations), Clinical Biochemistry (136 citations) and Health (153 citations). Emily Lutterloh has collaborated with scholars based in United States, Canada and Malawi. Frequent co-authors include K Southwick, Sudha Chaturvedi, Monica Quinn, Eli S. Rosenberg, Dina Hoefer, Howard A. Zucker, Vajeera Dorabawila, Ursula E. Bauer, Eleanor Adams and Debra Blog. Their work appears in journals such as American Journal of Infection Control, MMWR Morbidity and Mortality Weekly Report, Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology and Journal of the American Podiatric Medical Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.